About the Authors
- Parna Bhattacharya
-
* E-mail: Parna.Bhattacharya@fda.hhs.gov (PB); Hira.Nakhasi@fda.hhs.gov (HLN)
Affiliation Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
- Ranadhir Dey
-
Affiliation Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
- Pradeep K. Dagur
-
Affiliation Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America
- Amritanshu B. Joshi
-
Affiliation Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
- Nevien Ismail
-
Affiliation Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
- Sreenivas Gannavaram
-
Affiliation Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
- Alain Debrabant
-
Affiliation Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
- Adovi D. Akue
-
Affiliation Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Silver Spring, Maryland, United States of America
- Mark A. KuKuruga
-
Affiliation Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Silver Spring, Maryland, United States of America
- Angamuthu Selvapandiyan
-
Affiliation Institute of Molecular Medicine, New Delhi, India
- John Philip McCoy Jr.
-
Affiliation Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America
- Hira L. Nakhasi
-
* E-mail: Parna.Bhattacharya@fda.hhs.gov (PB); Hira.Nakhasi@fda.hhs.gov (HLN)
Affiliation Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceptualization: PB RD HLN. Formal analysis: PB RD SG. Investigation: PB RD NI. Methodology: AD PB RD AS. Resources: HLN JPM. Software: ADA ABJ MAK PKD. Supervision: HLN. Validation: HLN. Writing – original draft: PB RD HLN.